HSBC Holdings
AUPH icon

HSBC Holdings’s Aurinia Pharmaceuticals AUPH Stock Holding History

HSBC Holdings’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,514
Closed -$123K – 3029
2025
Q1 		$123K Sell
15,514
-102
-0.7% -$826 ﹤0.01% 2756
2024
Q4 		$141K Buy
15,616
+5,080
+48% +$41.4K ﹤0.01% 2816
2024
Q3 		$77.4K Sell
10,536
-4,017
-28% -$24.9K ﹤0.01% 2836
2024
Q2 		$81.8K Sell
14,553
-68,498
-82% -$361K ﹤0.01% 2769
2024
Q1 		$416K Buy
83,051
+12,095
+17% +$82K ﹤0.01% 2195
2023
Q4 		$637K Sell
70,956
-6,376
-8% -$52.5K ﹤0.01% 1952
2023
Q3 		$603K Sell
77,332
-2,668
-3% -$26.1K ﹤0.01% 1912
2023
Q2 		$799K Hold
80,000
– – ﹤0.01% 1799
2023
Q1 		$888K Sell
80,000
-2,303
-3% -$20.3K ﹤0.01% 1822
2022
Q4 		$350K Sell
82,303
-841
-1% -$4.88K ﹤0.01% 2454
2022
Q3 		$632K Sell
83,144
-150,063
-64% -$1.3M ﹤0.01% 2057
2022
Q2 		$2.32M Sell
233,207
-250,056
-52% -$2.8M ﹤0.01% 1514
2022
Q1 		$6.08M Buy
483,263
+2,598
+0.5% +$40.2K 0.01% 1114
2021
Q4 		$11.3M Buy
480,665
+409,080
+571% +$9.69M 0.01% 909
2021
Q3 		$1.6M Buy
71,585
+57,546
+410% +$913K ﹤0.01% 1630
2021
Q2 		$185K Buy
+14,039
New +$179K ﹤0.01% 2770
2021
Q1 		– Sell
-11,765
Closed -$161K – 2727
2020
Q4 		$161K Sell
11,765
-166
-1% -$2.42K ﹤0.01% 2869
2020
Q3 		$175K Sell
11,931
-3,319
-22% -$48.1K ﹤0.01% 2507
2020
Q2 		$248K Buy
+15,250
New +$244K ﹤0.01% 2227

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HSBC Holdings's AUPH Position: Q2 2025 in Review

HSBC Holdings sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2025, closing a stake of 15,514 shares — an estimated $123K sold.

HSBC Holdings first reported a position in AUPH in Q2 2020 and held it in 19 quarters. The position peaked at $11.3M in Q4 2021. 219 funds tracked by Wall St. Rank hold AUPH as of Q2 2025.

  • HSBC Holdings reported no remaining Aurinia Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • HSBC Holdings sold 15,514 Aurinia Pharmaceuticals shares in Q2 2025, an estimated $123K.
  • HSBC Holdings first reported a position in Aurinia Pharmaceuticals in Q2 2020 and held it in 19 quarters.
  • HSBC Holdings's Aurinia Pharmaceuticals position peaked at $11.3M in Q4 2021.
  • 219 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2025.

Based on HSBC Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.